BG109430A - FLUKOONAZOLE CAPSULES WITH IMPROVED EXEMPTION - Google Patents

FLUKOONAZOLE CAPSULES WITH IMPROVED EXEMPTION

Info

Publication number
BG109430A
BG109430A BG109430A BG10943006A BG109430A BG 109430 A BG109430 A BG 109430A BG 109430 A BG109430 A BG 109430A BG 10943006 A BG10943006 A BG 10943006A BG 109430 A BG109430 A BG 109430A
Authority
BG
Bulgaria
Prior art keywords
fluconazole
capsules
improved release
active ingredient
fluconazole capsules
Prior art date
Application number
BG109430A
Other languages
Bulgarian (bg)
English (en)
Inventor
Pal Fekete
Judit Virgula
Eva Furdyga
Huszar Magdolna Leventiszne
Imre Klebovich
Nemes Katalin Baloghne
Original Assignee
Egis Gyogyszergyar Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Rt. filed Critical Egis Gyogyszergyar Rt.
Publication of BG109430A publication Critical patent/BG109430A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG109430A 2003-07-02 2006-02-02 FLUKOONAZOLE CAPSULES WITH IMPROVED EXEMPTION BG109430A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0302030A HU227142B1 (en) 2003-07-02 2003-07-02 Capsule of improved release containing fluconazole

Publications (1)

Publication Number Publication Date
BG109430A true BG109430A (en) 2006-11-30

Family

ID=89981480

Family Applications (1)

Application Number Title Priority Date Filing Date
BG109430A BG109430A (en) 2003-07-02 2006-02-02 FLUKOONAZOLE CAPSULES WITH IMPROVED EXEMPTION

Country Status (10)

Country Link
EP (1) EP1648451A2 (cs)
CN (1) CN1812783A (cs)
BG (1) BG109430A (cs)
CZ (1) CZ200657A3 (cs)
EA (1) EA008585B1 (cs)
HU (1) HU227142B1 (cs)
PL (1) PL380995A1 (cs)
SK (1) SK50132006A3 (cs)
UA (1) UA82532C2 (cs)
WO (1) WO2005002553A2 (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032049A1 (de) * 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
GB0900786D0 (en) * 2009-01-19 2009-03-04 Natracine Uk Ltd Therapeutic compositions
MD3971C2 (ro) * 2009-04-29 2010-06-30 Дмитрий СКУРТУ Scaun-trenajor
RS56528B1 (sr) 2011-07-29 2018-02-28 Gruenenthal Gmbh Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu
AU2012292418B2 (en) 2011-07-29 2017-02-16 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
CA2917136C (en) 2013-07-12 2022-05-31 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
CN105616378A (zh) * 2014-10-31 2016-06-01 康普药业股份有限公司 一种氟康唑胶囊及其制备方法
WO2017042325A1 (en) 2015-09-10 2017-03-16 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
CN113230236A (zh) * 2021-04-29 2021-08-10 山东优杰生物科技有限公司 祛除灰指甲草本贴及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT75616A (en) * 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
US6214386B1 (en) * 1995-11-22 2001-04-10 Recordati, S.A. Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
ES2251985T3 (es) * 1999-03-24 2006-05-16 R.P. Scherer Technologies, Inc. Particula granulada para mejorar la solubilidad acuosa de farmacos, y su procedimiento de preparacion.
KR100694667B1 (ko) * 1999-12-08 2007-03-14 동아제약주식회사 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제
RU2201230C1 (ru) * 2001-12-24 2003-03-27 Закрытое акционерное общество "Брынцалов-А" Лекарственное средство флузол, обладающее противогрибковым действием

Also Published As

Publication number Publication date
EP1648451A2 (en) 2006-04-26
WO2005002553A2 (en) 2005-01-13
PL380995A1 (pl) 2007-04-16
EA200600085A1 (ru) 2006-08-25
CN1812783A (zh) 2006-08-02
SK50132006A3 (sk) 2006-05-04
CZ200657A3 (cs) 2006-04-12
HUP0302030A2 (hu) 2005-03-29
EA008585B1 (ru) 2007-06-29
HU0302030D0 (en) 2003-09-29
UA82532C2 (uk) 2008-04-25
HU227142B1 (en) 2010-08-30
WO2005002553A3 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
BG109430A (en) FLUKOONAZOLE CAPSULES WITH IMPROVED EXEMPTION
MY147641A (en) Fast release paracetamol tablets
RS50812B (sr) Suva granulisana kompozicija koja sadrži emtricitabin i tenofovir df
MY142067A (en) Xanthine derivatives as selective hm74a agonists, processes for the manufacture of said derivatives, formulations comprising these derivatives, and their use in the treatment of diseases where under-activation of the hm74a receptor contributes to the disease
WO2005079851A3 (en) Dopamine-agonist combination therapy with sedatives for improving sleep quality
EA200500909A1 (ru) Модифицированное высвобождение фармацевтической композиции
IL181524A (en) Heterocyclic compounds, pharmaceuticals containing them and their use in the preparation of drugs
IL184051A (en) Acetylated GLP-1 compounds, containing and using pharmaceutical preparations
AU2003274681A8 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
TW200731971A (en) Solid preparation
IL181445A0 (en) Use of (halobenzyloxy)benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium selective modulators
UA88300C2 (ru) Гидрогелевые композиции, которые содержат интерферон
EA200700201A1 (ru) Композиция таблетки пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
WO2007008752A3 (en) Sustained release pharmaceutical compositions for highly water soluble drugs
IL183357A0 (en) Oral medicament for the modified release of at least one active principle, in multimicrocapsule form
WO2008073282A3 (en) Ph sensitive matrix formulation
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
GB0606848D0 (en) Product, method of manufacture and use
WO2005007137A3 (de) Ambroxolhaltige tabletten
DE60331648D1 (de) Puffende orale darreichungsformen
AR024564A1 (es) Composicion que comprende esfingomielinasa para el uso como una preparacion dietetica, suplemento dietario o producto farmaceutico
WO2008133731A3 (en) Rapidly disintegrating low friability tablets comprising silica materials
WO2007016350A3 (en) Modified release tablet formulations with enhanced mechanical properties
WO2011090725A3 (en) Gastroretentive solid oral dosage forms with swellable hydrophilic polymer
EP1680098A4 (en) DELAYED RELEASE OF POSITIVELY-LOADED PHARMACOLOGICALLY EFFECTIVE MOLECULES FROM A POLYMER-CONTAINING MATRIX WITH POLARIZED OXYGENATOMES